Revival of the natural cycles in in-vitro fertilization with the use of a new gonadotrophin-releasing hormone antagonist (Cetrorelix): A pilot study with minimal stimulation

Human Reproduction

Volumn 14, Issue 3, 1999, Pages 683-688

  Rongieres Bertrand C ^a,b,c   Olivennes, F ^a,b,c   Righini, C ^a,b,c   Fanchin, R ^a,b,c   Taieb J ^a,b,c   Hamamah, S ^a,b,c   Bouchard, P ^a,b,c   Frydman, R ^a,b,c  

^a Departments of 'Obstetrics and Gynecology   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

Gonadotrophin releasing hormone antagonist; In vitro fertilization embryo transfer; Spontaneous cycle

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; GONADORELIN ANTAGONIST; HORMONE ANTAGONIST; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION; FERTILIZATION IN VITRO; FOLLICULAR PHASE; GROWTH; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; MENSTRUAL CYCLE; OOCYTE TRANSPORT; OVARY HYPERSTIMULATION; PILOT STUDY; PREGNANCY; PRONUCLEUS; SUBCUTANEOUS DRUG ADMINISTRATION; ULTRASOUND;

EID: 0342302492     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/14.3.683     Document Type: Article

References (54)

1. Aboulghar, M., Mansour, R., Serour, G. et al. (1995) In vitro fertilization in a spontaneous cycle: a successful simple protocol. J. Obstet. Gynaecol., 4, 337-340.
2. Albano, C., Smitz, J., Camus, M. et al. (1997) Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperStimulation. Fertil. Steril., 67, 917-922.
3. Assisted reproductive technology in the United States and Canada: 1994 results generated from the American Society for Reproductive Medicine/ Society for Assisted Reproductive Technology Registry (1996) Fertil. Steril., 66, 697-705.
4. Baien, A. (1995) The effects of ovarian induction with gonadotrophins on the ovary and uterus and implication for assisted reproduction. Hum. Reprod., 10, 2033-2037.
5. Brinsden, P., Wada, I., Tan, S.L. et al. (1995) Diagnosis, prevention, and management of ovarian hyperStimulation syndrome. Dr. J. Obstet. Gynaecol., 102, 767-772.
6. Bristow, R.E. and Karlan, B.Y. (1996) Ovulation induction, infertility, and ovarian cancer risk. Fertil. Steril., 66, 499-507.
7. Claman, P., Domingo, M., Garner, P. et al. (1993) Natural cycle in in-vitro fertilization-embryo transfer at the University of Ottawa: an inefficient .therapy for tubal infertility. Fertil. Steril., 60, 298-302.
8. Cluroe, A.D. and Synek, B.L. (1995) A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology, 27, 344-346.
9. Collins, J.A., Feeny, D. and Gunby, J. (1997) The cost of infertility diagnosis and treatment in Canada in 1995. Hum. Reprod., 12, 951-958.
10. Daya, S., Gunby, J., Hughes, E.G. et al. (1995) Natural cycles for in-vitro fertilization: cost effectiveness analysis and factors influencing outcome. Hum. Reprod., 10, 1719-1724.
11. De Mouzon, J. and Lancaster, P. (1997) World collaborative report on IVF. Preliminary data for 1995. J. Assist. Reprod. Genet., 14 (Suppl.), 251-265.
12. Diedrich, K., Diedrich, C., Santos, E. et al. (1994) Suppression of the endogenous LH-surge by the GnRH antagonist Cetrorelix during ovarian stimulation. Hum. Reprod., 9, 788-791.
13. Edwards, R., Lobo, R. and Bouchard, P. (1996) Time to revolutionize ovarian stimulation. Hum. Reprod., 11, 917-919.
14. Felderbaum, R., Reissman, T, Kupker, W. et al. (1996) Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antaaonist Cetrorelix at different dosages. J. Assist. Reprod. Genet., 13, 216-222.
15. Fishel, S.B., Edwards, R.G., Purdy, J.M. et al. (1985) Implantation, abortion, and birth after in vitro fertilization using the natural menstrual cycle or follicular stimulation with clomiphene citrate and human menopausal gonadotropin. J. In Vitro Fertil. Embryo Transfer, 2, 123-131.
16. FIVNAT (1997) Bilan F1VNAT 1996. Contracept. Fertil. Sex, 25, 499-502.
17. Foulot, H., Ranoux, C., Dubuisson, J.B. et al. (1989) In vitro fertilization without ovarian stimulation: a simplified protocol applied in 80 cycles. Fertil. Steril., 52, 617-621.
18. Frydman, R., Parneix, I., Belaisch-Allart, J. et al. (1988) LHRH agonists in IVF: different methods of utilization and comparison with previous ovulation stimulation treatments. Hum. Reprod., 3, 559-561.
19. Frydman, R., Cornel, C., de Ziegler, D. et al. (1991) Prevention of premature luteinizing hormone and progesterone rise with a GnRH antagonist Nal- Glu in controlled ovarian hyperStimulation. Fertil. Steril., 56, 923-927.
20. Frydman, R., Cornel, C., de Ziegler, D. et al. (1992) Spontaneous luteinizing hormone surges can be reliably prevented by the timely administration of a gonadotrophin releasing hormone antagonist (Nal-Glu) during the late follicular phase. Hum. Reprod., 7, 930-933.
21. Garcia, J. (1989) Return to the natural cycle for in vitro fertilization (Alleluia, Alleluia!). J. In Vitro Fertil. Embryo Transfer, 6, 67-68.
22. Gissler, M., Malin Silverio, M. and Hemminki, E. (1995) In-vitro fertilization pregnancies and perinatal health in Finland 1991-1993. Hum. Reprod., 10, 1856-1861.
23. Goldfarb, J.M., Austin, C., Lisbona, H. et al. (1996) Cost-effectiveness of / vitro fertilization. Obstet. Gynecol., 87, 18-21.
24. Karten, M.J., Hoeger, C.A., Hooh, W.A. et al. (1990) The development of safer antagonists; strategy and statut. In Bouchard, P., Haouar, F., Franchimont, P. and Schak, B. (eds), Recent Progress on GnRH and Gonadal Peptides. Eisevier, Paris, pp. 147-158.
25. Kettel, L.M., Roseff, S.J., Chiu, T.C. et al. (1991) Follicular arrest during the midfollicular phase of the menstrual cycle; a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition. J. Clin. Endocrinol. Metab., 73, 644-649.
26. Lenton, E.A. and Woodward, B. (1993) Natural-cycle versus stimulated-cycle IVF: is there a role for IVF in the natural cycle? J. Assist. Reprod. Genet., 10, 406-408.
27. Lenton, E.A., Cooke, I.D., Hooper, M. et al. (1992) In vitro fertilization in the natural cycle. Baillière's Clin. Obstet. Gynaecol., 6, 229-244.
28. Leroy, I., d'Acremont, M.F., Brailly-Tabard, S. et al. (1995) A single injection of gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge. Fertil. Steril., 62, 461-467.
29. Liu, H.C., Lai, Y.M., Davis, O. et al. (1992) Improved pregnancy outcome with gonadotropin releasing hormone agonist (GnRH-a) stimulation is due to the improvement in oocyte quantity rather than quality. J. Assist. Reprod. Genet., 9, 338-344.
30. Meldrum, D.R., Rivier, J., Garzo, G. et al. (1994) Successful pregnancies with unstimulated cycle oocyte donation using an antagonist of gonadotropinreleasing hormone. Fertil. Steril., 61, 556-557.
31. Nagy, Z.P., Liu, J., Joris, H. et al. (1995) The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. Hum. Reprod., 10, 1123-1129.
32. Ndukwe, G., Thorton, S., Fishel, S. et al. (1997) 'Curing' empty follicle syndrome. Hum. Reprod., 12, 21-23.
33. Norman, R., Payne, D. and Matthews, C. (1995) Pregnancy following ICSI of a single oocyte during a natural cycle. Hum. Reprod., 10, 1626-1627.
34. Olivennes, F. and Frydman, R. (1998) Friendly IVF: the way of the future? Hum. Reprod., 13, 1121-1124.
35. Olivennes, F., Fanchin, R., Bouchard, P. et al. (1994) The single or dual administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in an i;i vitro fertilization embryo transfer program. Fertil. Steril., 62, 468-476.
36. Olivennes, F., Fanchin, R., Bouchard, P. et al. (1995) Scheduled administration of GnRH antagonist (Cetrorelix) on day 8 of in vitro fertilization cycles: a pilot study. Hum. Reprod., 10, 1382-1386.
37. Olivennes, F., Kadhel, P., Rufat, P. et al. (I996a) Perinatal outcome of twin pregnancies obtained after in vitro fertilization: comparison with twin pregnancies obtained spontaneously or after ovarian stimulation. Fertil. Steril., 66, 105-109.
38. Olivennes, F., Lima-Ferreira, A., Bergère, M. et al. (1996b) L'injection intracytoplasmique de spermatozoïde. Presse Méd., 25, 1599-1603.
39. Olivennes, F., Alvarez, S., Bouchard, P. et al. (1998) The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2 mg. Hum. Reprod., 13, 2411-2414.
40. Palermo, G.D., Cohen, J. and Rosenwaks, Z. (1996a) Intracytoplasmic sperm injection: a powerful tool to overcome fertilization failure. Fertil. Steril., 65, 899-908.
41. Palermo, G.D., Colombcro, L.T., Schattman, G.L. et al. (1996b) Evolution of pregnancies and initial follow-up of newboms delivered after intracytoplasmic sperm injection. JAMA, 276, 1893-1897.
42. Paulson, F.J., Sauer, M.V., Francis, M.M. et al. (1990a) In vitro fertilization in unstimulated cycles: a clinical trial using hCG for timing of follicle aspiration. Obstet. Gynecol., 76, 788-791.
43. Paulson, F.J., Sauer, M.V. and Lobo, R.A. (1990b) Embryo implantation after human in-vitro fertilization: importance of endometrial receptivity. Fertil. Steril., 53, 870-874.
44. Paulson, F.J., Sauer, M.V., Francis, M.M. et al. (1992) In vitro fertilization in unstimulated cycles: the University of Southern California Experience. Fertil. Steril., 57, 290-293.
45. Ferez, C., Koeppel, B., Olivennes, F. etal. (1998) FIV + ICSI: retentissement psychologique sur les couples. Contracept. Fertil. Sex, 26, 713-717.
46. Hamsewak, S.S., Kumar, A., Welsby, R. et al. (1990) Is analgesia required for transvaginal single follicle aspiration in in vitro fertilization? A double blind study. J. In Vitro Fertil. Embryo Transfer, 7, 103-106.
47. Rizk, B. and Smitz, J. (1992) Ovarian hyperstimulation syndrome after superovulation using GnRH agonists for IVF and related procedures. Hum. Reprod., 7, 320-327.
48. Rossing, M.A., Daling, J.R., Weiss, N.S. et al. (1994) Ovarian tumors in cohort of infertile women. N. Engl. J. Med., 331, 771-776.
49. Schoolcraft, W.B., Schlenker, T., Adler, A. and Alikani, M. (1996) A model for the incorporation of intracytoplasmic sperm injection into a private practice of in vitro fertilization program. Fertil. Steril., 65, 258-261.
50. Tallo, C.P., Vohr, B., Oh, W. et al. (1995) Maternal and neonatal morbidity associated with m vitro fertilization. J. Pediatr., 127, 794-800.
51. Tupin, P., Blondel, B. and Kaminski, M. (1993) Trends in multiple deliveries and infertility treatments in France. Br. J. Obstet Gynaecol., 100, 383-385.
52. Ubaldi, F., Nagy, Z., Janssenswillen, C. et al. (1997) Ovulation by repeated human chorionic gonadotrophin in 'empty follicle syndrome' yields a twin clinical pregnancy. Hum. Reprod., 12, 454-456.
53. Venn, A., Watson, L., Lumley, J. et al. (1995) Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Obstet. Gynecol. Surv., 346, 995-1000.
54. Whittemore, A.S., Harris, R. and Itnyre, J. (1992) Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative ovarian cancer group. Am. J. EpidemioL, 136, 1212-1220.